Navigation Links
Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year
Date:11/10/2008

ent of Earnings

Net revenues

Capital sales $1,044.0 $940.7

Rental revenues 463.7 415.8

Total revenues 1,507.7 1,356.5

Cost of revenues

Cost of goods sold 618.6 546.9

Rental expenses 219.6 207.1

Total cost of revenues 838.2 754.0

Gross profit

Capital sales 425.4 393.8

Rental revenues 244.1 208.7

Total gross profit 669.5 602.5

As a percentage of sales 44.4% 44.4%

Operating expense 543.9 483.0

As a percentage of sales 36.1% 35.6%

Litigation and special (charges)/credits, net (22.8) 1.4

Operating profit 102.8 120.9

Other income/(expense), net (10.5) (14.7)

Income tax expense (1) 25.2 35.8

Income from continuing operations $67.1 $70.4

Diluted earnings per share:

Earnings per share from continuing

operations $1.07 $1.13

Average common shares outstanding - diluted

(thousands) 62,590 62,115

Dividends per common share $0.78 $1.14

Consolidated Cash Flows from Operations (2)

Cash flow from operations $270.5 $285.3

Less: capital expenditures
'/>"/>

SOURCE Hill-Rom Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Hill-Rom Introduces New Wound Therapy Surface With Innovative Safety and Treatment Features
2. Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2008 Results
3. Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update
4. BMP Sunstone Reports Third Quarter 2008 Financial Results
5. Endocare Reports Financial Results for Third Quarter 2008
6. Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs
7. Isis Reports Financial Results and Highlights for Third Quarter of 2008
8. OncoGenex Reports Third Quarter Financial Results
9. American Oriental Bioengineering Reports Third Quarter 2008 Financial Results
10. AutoImmune Inc. Reports 2008 Third Quarter Financial Results
11. Dendreon Reports Third Quarter 2008 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...f ultrasmall transistors and more powerful compute...g nanowires are closer to reality after a key disc... the University of California at Los Angeles. , ...es with layers of different materials that are sha...cal requirement for making efficient transistors o...
(Date:11/25/2009)...-- Biotech firm Replikins Ltd., which has analyzed...ic through the prediction, outbreak, and progress ...est biochemical analysis of the virus. The new dat...") virus has dropped from its peak of 3.7 (s.d. 4....ng of 2009 to resting non-epidemic levels this wee...
(Date:11/25/2009)...re/--Formanybusinesses,2009hasbeenapainfulyear.Not...ngnetworkofexpertphysiciansspecializingexclusively...wnthenumberof physiciansinitsnetwork sinceNove...dmorephysician-ownedcenters,includingoneinPuertoRi...gicMDhasopened13newbioidenticalhormonespecialtypra...
(Date:11/25/2009)...wire-Asia/ -- Sinovac Biotech Ltd. ( SVA),a leadi...oday that it executed,a joint venture (JV) agreeme...y Co., Ltd. (Sinovac Dalian). The JV will research...cines. Sinovac will contribute its expertise,and e...class vaccines; the,other party will bring its lan...
Breaking Biology Technology:Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3
...ent Results in Improvements in Physical ...AN FRANCISCO, Oct. 27 More than half of patients,...of golimumab (CNTO 148),50 mg and 100 mg, an inves...ents in the joint and skin symptoms of active psor...stained through one year.,Golimumab-treated patien...
...apeutics,(Nasdaq: FOLD ) will announce third quar... of markets on Monday, November 3, 2008. The resul...nce call and webcast that,afternoon at 5 p.m. ET.,... the conference call at,5 p.m. ET by dialing 877-4...al). A telephonic replay of the call will be avail...
...FirstCall/ -- China Medical,Technologies, Inc. (th...ed,medical device company that develops, manufactu...ucts today announced that it will report selected,... revenues, net income and,earnings per ADS for the...2Q FY2008") on November 18, 2008 and full unaudite...
Other Biology Technology:One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 2One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 3One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 4One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 5One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 6One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 7One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 8One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 9Amicus Therapeutics Announces Third Quarter 2008 Results Release Date 2China Medical Technologies Announces Reporting Dates for the September Quarter Results and Addresses Investor Inquiries 2China Medical Technologies Announces Reporting Dates for the September Quarter Results and Addresses Investor Inquiries 3
(Date:11/25/2009)...he heart pumps some 250 million liters of blood th...e fibers of the heart have to be extremely durable...uer, vice chair of the Department of Medicine III ... Dr. H. A. Katus), has discovered a protein that i...scular unit, the sarcomere. In cooperation with ot...
(Date:11/24/2009)...ors to understanding how sounds associated with Na...al or if they hear it at all. , The same type o...uses to detect flaws in the space shuttle,s behemo...o peek inside the giant head of a whale. The scans... of a whale,s hearing anatomy using a breakthrough...
(Date:11/24/2009)...er 24, 2009) -- The Wildlife Conservation Society ...last remaining population of Siberian tigers has l...e of poaching and habitat loss. , WC...ls of what needs to be done to protect remaining p... The report was released by the Siberian Tige...
Breaking Biology News(10 mins):New genetic cause of cardiac failure discovered 2Rocket science leads to new whale discovery 2Report shows dramatic decline in Siberian tigers 2Palatin Technologies Inc to Report Fourth Quarter and Fiscal Year 2009 Results 3B Teleconference and Webcast to be held on September 8 2009 13859 1Palatin Technologies Inc to Report Fourth Quarter and Fiscal Year 2009 Results 3B Teleconference and Webcast to be held on September 8 2009 13859 2Delcath Systems to Present at Rodman 26 Renshaw 11th Annual Healthcare Conference 56246 1Mindray DS USA Appoints Michael Thompson Vice President of U S Ultrasound Sales 56243 1Mindray DS USA Appoints Michael Thompson Vice President of U S Ultrasound Sales 56243 2Mindray DS USA Appoints Michael Thompson Vice President of U S Ultrasound Sales 56243 3
...in sequence data available, scientists are increas... of information that determines a protein,s functi...proteins differ, such information can also help sc...cientists at the U.S. Department of Energy,s Brook...program "to sort the informational ,wheat, from th...
...es plays a role in how our arms and legs develop a... bits of material once dismissed as genetic "junk,...Harvard University. , The research, available toda...ists understand whether bits of RNA called microRN...ment not just by strategically turning off gene ac...
...ationwide will today for the first time be able to...ch for genes that underlie a range of chronic dise...t and other common diseases have been providing bl... of a project hosted by The University of Manchest...re to study genes in chronic diseases. The project...
Other Biology News:Scientists develop protein-sequence analysis tool 2MicroRNA may have fail-safe role in limb development 2'Dating agency' boosts hunt for disease genes 2
... inL10 Workstation from Caliper represents a revol...y, offering for the first time the ability to gene...ly react to changing conditions. In addition, eac... viscosity due to changes in temperature, and offe...
... Series of systems provide fast and reliable scala...s, proteomics and drug development laboratories. S...urations; Mini Workstation Series, Application Ser...cation Series systems use a revolutionary new base...
...over 20 years of experience in providing versatile...the Freedom EVO platform delivers even more flexib... future needs. Together with the new easy-to-use s...to successfully operate genomics, proteomics, and ...
...n Filter is a novel disposable spin filtration dev...f bacterial lysates in plasmid purification proced...disposable spin filtration device especially desig...in plasmid purification procedures. The neutralize...
Biology Products: